Draft guidelines for the National Health Service in England recommend that patients suffering from severe and persistent indigestion should be offered a quick “sponge in the gullet” test to check for oesophageal cancer. The proposal aims to provide a less invasive alternative to hospital endoscopy, which is currently in high demand across the NHS.
How the capsule test works
The procedure involves the patient swallowing a small capsule attached to a thread. Once the capsule dissolves in the stomach, it releases a tiny sponge. A doctor then gently pulls the sponge back out through the mouth, collecting cells from the lining of the oesophagus during the process. The entire test can be completed in a GP surgery in just a few minutes.
Prof Jonathan Benger, chief executive of the National Institute for Health and Care Excellence (NICE), stated that these tests offer a “quick and less invasive” method to detect concerning cellular changes. This approach helps identify patients who require further diagnostic tests or treatment, while sparing others from more complex procedures.
Addressing the endoscopy bottleneck
Heartburn and acid reflux are common symptoms associated with Barrett’s oesophagus, a condition where cells in the food pipe begin to change. This change increases the long-term risk of developing cancer. It is estimated that one to two adults in every 100 have Barrett’s oesophagus, although most will not develop cancer. However, the high demand for NHS endoscopy services means that many patients with this condition are not checked as frequently as recommended.

Prof Peter Johnson, the national clinical director for cancer at NHS England, highlighted that thousands of patients have already benefited from this efficient test during previous pilot programs. He noted that providing an easier way to check for changes in the oesophagus lining makes a significant difference for patients. It reduces the need for complicated endoscopy tests and helps the NHS free up resources to find cancers at an earlier stage.
The sponge tests are already available in some parts of England but could now be rolled out nationwide under the new recommendations. NICE emphasizes that while the tests are effective, they do not identify every case of cancer. People who receive a clear result should still be monitored in the long term, particularly if they continue to experience symptoms.
Reflux disease, which causes heartburn and a sour taste in the mouth, is often linked to a weakened sphincter at the bottom of the oesophagus. Factors such as being overweight, smoking, and drinking alcohol can increase the risk of reflux. By offering these sponge tests to those with bad indigestion, the NHS hopes to catch potential issues earlier and manage patient flow more effectively.
Source: BBC

